Fig. 2. Kaplan-Meier estimates of overall survival according to the ASAL score and prognostic model: (A) ASAL score in the training cohort, (B) ASAL score in the validation cohort, (C) prognostic model in the training cohort, (D) prognostic model in the validation cohort, (E) prognostic model limited to treatment-naive patients in the training cohort, and (F) prognostic model limited to treatment-naive patients in the validation cohort. ASAL, aspartate aminotransferase-albumin.